Sangamo Therapeutics and Astellas Collaborate on Innovative Gene Therapy for Neurological Diseases

FDA Clears IND for Arbor Biotechnologies’ ABO-101 Gene Editing Therapeutic for Primary Hyperoxaluria Type 1

Fortis Healthcare Acquires Stake in Agilus Diagnostics

FDA Approves BRAFTOVI® Combination Regimen as First-Line Treatment for BRAF V600E-Mutant Metastatic Colorectal Cancer

The Role of Big Data in Precision Medicine

Caris Life Sciences Celebrates 1,000+ Precision Medicine Studies, Advancing Cancer Research and Patient Outcomes

OncoHelix and Qualisure Diagnostics Partner to Bring Thyroid GuidePx® Test to Canadian Patients

Gates Foundation Invests $50 Million in Tessera Therapeutics to Advance Gene Therapy for Sickle Cell Disease

FDA Approves Ensartinib (Ensacove) as First-Line Treatment for ALK-Positive NSCLC

Guardant Health and Boehringer Ingelheim Collaborate to Advance Liquid Biopsy CDx for HER2-Targeted Therapy in NSCLC

Cartherics Receives $300K G-Rex Grant to Advance Cancer Cell Therapy Manufacturing

Roche Revolutionizes Mass Spectrometry Diagnostics with Launch of cobas® Mass Spec Solution

Complete Genomics Partners with Eurofins Clinical Enterprise to Expand Sequencing Service Offerings

NeuroKaire Secures $10M to Transform Precision Medicine in Psychiatry and Neurology

Redcliffe Labs Announces Leadership Transition to Drive Healthcare Accessibility

Home
/
update
/
details

PathPresenter Secures $7.5 Million to Drive Adoption of Digital Pathology Workflow Solutions

NextEdge Admin

13 Sep 2024

2 min 4 sec

PathPresenter, a global image-sharing platform for pathology, has secured $7.5 million in Series A funding to accelerate the adoption of its enterprise pathology workflow solution. The funding round was led by AVANT BIO, with support from Barco NV and Modi Ventures. The investment will be used to enhance platform features, boost interoperability, expand the engineering and commercial teams, and achieve key regulatory milestones.

Founded by dermatopathologist and digital pathology expert Dr. Rajendra Singh, PathPresenter initially started as a free online tool for pathology education. It quickly grew into the world’s largest digital pathology community, boasting over 50,000 users across 172 countries. To meet institutional demands, PathPresenter developed a secure, scalable enterprise platform designed for clinical care, remote consultations, and research. The platform’s vendor-agnostic approach allows it to integrate seamlessly with various systems, offering a comprehensive workflow solution for digital pathology.

Today, PathPresenter supports more than 50 top-tier hospitals, labs, and pharmaceutical companies, enabling efficient digital pathology workflows that connect institutions with global pathology expertise. The platform incorporates cutting-edge artificial intelligence (AI) algorithms to improve patient outcomes and create new revenue streams from digital pathology investments. By democratizing access to global pathology knowledge, PathPresenter aims to enhance clinical care, education, and research through its innovative, AI-driven enterprise solution.